ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0323

Automated Effusion-Synovitis Volume is Prognostic and Responsive to Knee Osteoarthritis Progression: Data from the Osteoarthritis Initiative

Jeffrey Driban1, Kate Lapane2, Shao-Hsien Liu2, Jonggyu Baek2, Grace Lo3, Matthew Harkey4, Charles Eaton5, James Mackay6, Timothy McAlington7, Mohammad Chowdhury8, Zhen Cao9, Juan Shan10 and Ming Zhang11, 1University of Massachusetts Chan Medical School, Marlborough, NH, 2UMass Chan Medical School, Worcester, MA, 3Baylor College of Medicine / MEDVAMC, Houston, TX, 4Michigan State University, East Lansing, MI, 5Brown University, Pawtucket, RI, 6University of Cambridge; Norwich Medical School, San Diego, CA, 7UMass Chan School of Medicine, Arlington, MA, 8Pace University, New York City, NY, 9Boston University, Boston, MA, 10Pace University, New York, NY, 11Boston University, Westford, MA

Meeting: ACR Convergence 2025

Keywords: Magnetic resonance imaging (MRI), Osteoarthritis, Synovitis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, October 26, 2025

Title: (0306–0336) Osteoarthritis – Clinical Poster I

Session Type: Poster Session A

Session Time: 10:30AM-12:30PM

Background/Purpose: Semi-quantitative and semi-automated quantitative measurements of effusion-synovitis (ES) are prognostic for knee OA progression. Changes in these metrics relate to changes in knee pain. However, these traditional methods require readers to review or measure MRIs, leading to reader variability and significant time demands. An automated approach could enable quantitative ES volume measurements that can be rapidly deployed on large datasets without variations between readers. Hence, we evaluated the prognostic and construct validity of an automated quantitative measurement of ES volume by comparing its relationship to knee OA progression against that of a well-established semi-automated ES volume.

Methods: We conducted knee-based analyses among participants in the Osteoarthritis Initiative with bilateral knee MRIs and at least one knee with Kellgren-Lawrence (KL) grade ≥ 1 and a WOMAC pain score ≥ 10/100. We included participants with ES measurements at the 12- and 36-month OAI visits. A trained reader measured whole-knee ES volume on MRIs using our semi-automated software. To develop an automated measurement, we implemented a deep neural network approach based on the 3D U-Net architecture developed with the Medical Open Network for Artificial Intelligence (MONAI) framework. The model was trained using a different dataset with data augmentation techniques, including random affine transformations, spatial flips, and intensity shifts to enhance robustness. We calculated Pearson Correlation Coefficients between the automated and semi-automated ES volumes (cross-sectionally and 2-year change) and created Bland-Altman plots. To assess prognostic validity, we examined how ES volumes at the 12-month visit related to changes in radiographic severity (KL and joint space narrowing [JSN] progression) over the subsequent 3 years. To assess construct validity, we examined concurrent change in ES volumes with 2-year progression in KL grade, JSN grade, or WOMAC knee pain scores (change > 10/100 points). We performed knee-based analyses using logistic regression with repeated measures to adjust for correlations between knees within each person.

Results: Among the 506 participants (1,011 knees), 56% were female with a mean (SD) age = 61 (9) years and BMI = 29.3 (4.3) kg/m2. The sample included 82 (8%) knees with KL progression, 103 (10%) with medial JSN progression, and 126 (12%) with knee pain worsening. Cross-sectionally, the automated method yielded smaller volumes than the semi-automated method (Figure 1B); however, these differences were attenuated when assessing longitudinal change (Figure 1D). Despite these differences, the automated ES volume strongly correlated with the semi-automated volume (r = 0.89; Figure 1A) and volume change (r = 0.84; Figure 1C). The table shows that the automated and semi-automated ES volumes had consistent statistically significant associations with every outcome.

Conclusion: The automated ES volume had strong prognostic and construct validity regarding radiographic and pain outcomes. The automated method offers an efficient strategy to quantify ES in studies with large sample sizes. It may provide a cost-effective approach to screen MRIs in future clinical trials.

Supporting image 1Table. Automated quantitative measurements of effusion-synovitis volume (cm3) have similar prognostic and construct validity as well-established semi-automated effusion-synovitis volumes.

Supporting image 2Figure 1. Cross-sectionally, the automated effusion-synovitis volumes (cm^3) are typically smaller than the semi-automated effusion-synovitis volumes (A [Scatter Plot], B [Bland-Altman Plot]); however, these differences are attenuated when examining the two-year change in both measures (C [Scatter Plot], D [Bland-Altman Plot]). In Figures A and C, the red line is the line of identity/equality, and correlations are reported with 95% confidence intervals (CI). In Figures B and D, the middle red line is the mean difference between the methods. The upper and lower red lines represent the upper and lower bounds of the 95% confidence interval, respectively.


Disclosures: J. Driban: None; K. Lapane: None; S. Liu: None; J. Baek: None; G. Lo: None; M. Harkey: None; C. Eaton: None; J. Mackay: AstraZeneca, 3, Blue Earth Diagnostics, 3; T. McAlington: Anika, 2, Grunenthal, 2, Kiniksk, 2, Kolon TissueGene, Inc., 2, Medipost, 2, Novan, 2, Organogenesis, 2, Regeneron, 2, Remedium-Bio, 2, Samumed, 2, Sanofi, 2, Scarcell, 2, Visor, 2; M. Chowdhury: None; Z. Cao: None; J. Shan: None; M. Zhang: None.

To cite this abstract in AMA style:

Driban J, Lapane K, Liu S, Baek J, Lo G, Harkey M, Eaton C, Mackay J, McAlington T, Chowdhury M, Cao Z, Shan J, Zhang M. Automated Effusion-Synovitis Volume is Prognostic and Responsive to Knee Osteoarthritis Progression: Data from the Osteoarthritis Initiative [abstract]. Arthritis Rheumatol. 2025; 77 (suppl 9). https://acrabstracts.org/abstract/automated-effusion-synovitis-volume-is-prognostic-and-responsive-to-knee-osteoarthritis-progression-data-from-the-osteoarthritis-initiative/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2025

ACR Meeting Abstracts - https://acrabstracts.org/abstract/automated-effusion-synovitis-volume-is-prognostic-and-responsive-to-knee-osteoarthritis-progression-data-from-the-osteoarthritis-initiative/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology